RSS

Owlstone Medical

Diagnostics company, Owlstone Medical, has raised $15 million to drive the global commercialisation of its Breath Biopsy device. more

Devices

Pilot study demonstrates FAIMS technology can detect patients inadequately prepped prior to colonoscopy with 100% sensitivity more

News

Diagnostics company Owlstone Medical has welcomed Tony Blair to its headquarters in Cambridge. more

News

Diagnostics company Owlstone Medical has commenced a 1,400 patient clinical trial for the early detection of colorectal cancer. more

News